Investigating the effect of tannin films prepared by low-energy electron beam deposition on the inhibition of bone tumors

1. A multifunctional antibacterial coating on bone implants for osteosarcoma therapy and enhanced osteointegration

2. Bifunctional, copper-doped, mesoporous silica nanosphere-modified, bioceramic scaffolds for bone tumor therapy10.3389/fchem.2020.610232 ↗

3. Bismuth-coated 80S15C bioactive glass scaffolds for photothermal antitumor therapy and bone regeneration10.3389/fbioe.2022.1098923 ↗

4. Layer-by-layer assembled black phosphorus/chitosan composite coating for multi-functional PEEK bone scaffold10.1016/j.compositesb.2022.110266 ↗

5. Fabrication of curcumin-modified TiO2 nanoarrays via cyclodextrin based polymer functional coatings for osteosarcoma therapy10.1002/adhm.201901031 ↗

6. Novel bone tumor cell targeting nanosystem for chemo-photothermal therapy of malignant bone tumors

7. Tannic acid synergistically enhances the anticancer efficacy of cisplatin on liver cancer cells through mitochondria-mediated apoptosis10.3892/or.2019.7281 ↗

8. Zinc-based tannin-modified composite microparticulate scaffolds with balanced antimicrobial activity and osteogenesis for infected bone defect repair10.1002/adhm.202300303 ↗

9. Recyclable glutaraldehyde cross-linked polymeric tannin to sequester hexavalent uranium from aqueous solution10.1016/j.molliq.2019.02.040 ↗

10. Silver nanoparticles fabricated by tannic acid for their antimicrobial and anticancerous activity10.1016/j.inoche.2022.109532 ↗

11. The modification of titanium surface by decomposition of tannic acid coating10.3390/app13085204 ↗

12. The application of tannic acid in orthopedics10.3389/fmats.2021.801369 ↗

13. Hydroxyapatite/tannic acid composite coating formation based on ti modified by TiO2 nanotubes10.1016/j.colsurfb.2020.111304 ↗

14. Ag-incorporated polydopamine/tannic acid coating on titanium with enhanced cytocompatible and antibacterial properties

15. Low-energy electron beam deposition of coatings based on lignin and quercetin, their structure and properties10.1016/j.vacuum.2022.111416 ↗

16. Low-energy electron beam deposition of metal-containing organic-inorganic coatings with selective activity against microorganisms10.1016/j.vacuum.2022.111803 ↗

17. Low-energy electron beam deposition of coatings based on tannin and corn starch, their structure and properties10.1016/j.apsusc.2023.158540 ↗

18. Structure and properties of polyaniline nanocomposite coatings containing gold nanoparticles formed by low-energy electron beam deposition10.1016/j.apsusc.2017.09.225 ↗

19. Multifunctional tannic acid-alendronate nanocomplexes with antioxidant, anti-inflammatory, and osteogenic potency10.3390/nano11071812 ↗

20. Microfibrillated cellulose films containing chitosan and tannic acid for wound healing applications

21. Mechanism of extracting germanium from Ge-containing solution with tannins10.3390/met13040774 ↗

22. Pharmacological effects and mechanisms of tannic acid10.1016/j.biopha.2022.113561 ↗

23. Recent advances in tannic acid (gallotannin) anticancer activities and drug delivery systems for efficacy improvement; A comprehensive review10.3390/molecules26051486 ↗

24. Tannic acid enhances cisplatin effect on cell proliferation and apoptosis of human osteosarcoma cell line (U2OS)10.1007/s43440-021-00330-3 ↗

25. Tannic acid synergistically enhances the anticancer efficacy of cisplatin on liver cancer cells through mitochondria‑mediated apoptosis, (n.d.). https://www.spandidos-publications.com/10.3892/or.2019.7281 (accessed October 23, 2023).

26. Mitochondrial genome and functional defects in osteosarcoma are associated with their aggressive phenotype10.1371/journal.pone.0209489 ↗

27. S. Smeland, S.S. Bielack, J. Whelan, M. Bernstein, P. Hogendoorn, M.D. Krailo, R. Gorlick, K.A. Janeway, F.C. Ingleby, J. Anninga, I. Antal, C. Arndt, K.L.B. Brown, T. Butterfass-Bahloul, G. Calaminus, M. Capra, C. Dhooge, M. Eriksson, A.M. Flanagan, G. Friedel, M.C. Gebhardt, H. Gelderblom, R. Goldsby, H.E. Grier, R. Grimer, D.S. Hawkins, S. Hecker-Nolting, K. Sundby Hall, M.S. Isakoff, G. Jovic, T. Kühne, L. Kager, T. Von Kalle, E. Kabickova, S. Lang, C.C. Lau, P.J. Leavey, S.L. Lessnick, L. Mascarenhas, R. Mayer-Steinacker, P.A. Meyers, R. Nagarajan, R.L. Randall, P. Reichardt, M. Renard, C. Rechnitzer, C.L. Schwartz, S. Strauss, L. Teot, B. Timmermann, M.R. Sydes, N. Marina, Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort, European Journal of Cancer 109 (2019) 36–50. https://doi.org/10.1016/j.ejca.2018.11.027.10.1016/j.ejca.2018.11.027 ↗

28. New Horizons in the Treatment of Osteosarcoma | NEJM, (n.d.). https://www.nejm.org/doi/10.1056/NEJMra2103423 (accessed October 23, 2023).

29. Osteosarcoma in adolescents and young adults10.3390/cells10102684 ↗

30. Post-translational modifications of PCNA in control of DNA synthesis and DNA damage tolerance-the implications in carcinogenesis10.7150/ijbs.64628 ↗

31. A lesson for the maestro of the replication fork: targeting the protein-binding interface of proliferating cell nuclear antigen for anticancer therapy10.1002/jcb.30265 ↗

32. PCNA, the maestro of the replication fork10.1016/j.cell.2007.05.003 ↗

33. M. Cardano, C. Tribioli, E. Prosperi, Targeting Proliferating Cell Nuclear Antigen (PCNA) as an Effective Strategy to Inhibit Tumor Cell Proliferation, Current Cancer Drug Targets 20 (n.d.) 240–252.10.2174/1568009620666200115162814 ↗

34. L. Zhang, Z. Lu, X. Zhao, Targeting Bcl-2 for cancer therapy, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1876 (2021) 188569. https://doi.org/10.1016/j.bbcan.2021.188569.10.1016/j.bbcan.2021.188569 ↗

35. Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins10.1038/s41580-018-0089-8 ↗

36. BCL-2 protein family: attractive targets for cancer therapy10.1007/s10495-022-01780-7 ↗